Navigation Links
Safe and effective therapy discovered for patients with protein-losing enteropathy
Date:12/7/2007

(December 6, 2007 - La Jolla, CA) Researchers at the Burnham Institute for Medical Research (Burnham Institute) have developed the first model to study intestinal protein leakage in mice, allowing the team to control and replicate both genetic deficiencies and environmental damages in an in vivo setting. Protein-losing enteropathy (PLE) encompasses conditions that involve the abnormal leakage of blood proteins into the digestive tract. One type of PLE is observed in children who have undergone Fontan surgery, a procedure used to alleviate certain congenital heart defects. Half of post-Fontan patients who develop PLE die from this condition, due largely to therapeutic options that are inadequate and accompanied by serious side effects.

A study performed by the laboratory of Hudson Freeze, Ph.D., at the Burnham Institute has been published in the Journal of Clinical Investigation (JCI), describing both the science behind PLE and also a way to treat the disease that side steps some of the severe complications of current treatments.

Dr. Freezes group, led by Lars Bode, Ph.D., identified commonalities in clinical observations of PLE patients that recognized several key features of PLE pathogenesis; in particular, it is episodic and its onset is often associated with viral infection and a proinflammatory state. The most intriguing commonality that the group observed in PLE patients is the specific loss of heparan sulfate (HS) from intestinal epithelial cells during PLE episodes. Importantly, the study revealed that loss of HS is a key factor in promoting protein leakage and makes the intestine more susceptible to inflammation and increased hypertension. Co-author Simon Murch, M.D., University of Warwick, UK, first noticed the loss of intestinal cell HS in one of their previous collaborations.

When heparan sulfate is missing, the inflammatory molecules pack a much greater punch and impact than when HS is there on the cell surface, sa
'/>"/>

Contact: Andrea Moser
amoser@burnham.org
858-646-3146
Burnham Institute
Source:Eurekalert

1

GOOD

Page: 1 2

Related biology news :

1. Gamma globulin effective in treating eye infections caused by adenoviruses
2. UC health news: molecular pathway may predict chemotherapy effectiveness
3. Socioeconomic position associated with effectiveness of HIV drugs
4. New nanoparticle vaccine is more effective but less expensive
5. MIT model could improve some drugs effectiveness
6. Trial seeks genetic fingerprint for predicting drug effectiveness
7. New hope for horse lovers as effective control for killer ragwort is proposed
8. Quantitative PET imaging finds early determination of effectiveness of cancer treatment
9. Gene, stem cell therapy only needs to be 50 percent effective to create a healthy heart
10. Tamiflu effective for treatment and prevention of influenza in children 1 year and older
11. A new radiation therapy treatment developed for head and neck cancer patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)... WEST LAFAYETTE, Ind. - Researchers at Purdue Univ...g damaged nerve fibers in spinal cord injuries usi...ood shortly after an accident. , The synthetic "...t 60 nanometers in diameter, or roughly 100 times ... Researchers have been studying how to deliver dru...
(Date:11/6/2009)...ee-dwelling ants generally live in harmony with th... when they run out of space in their trees of choi...ees. , The research, published in the November i... document that ants bore into live trees, and it r...between ants and plants. , Ants and certain spec...
(Date:11/5/2009)...nt State University has been awarded a training gr...ience Foundation under its Integrative Graduation ...his is the first IGERT grant to be awarded to Kent...can Recovery and Reinvestment Act of 2009, runs th...hat focuses on environment aquatic resource sensin...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Ants are friendly to some trees, but not others 2Kent State receives $2.7 million NSF training grant for environmental aquatic resource sensing 2Sysmex America Debuts High end Sample Management System During AACC 52129 1Sysmex America Debuts High end Sample Management System During AACC 52129 2Sysmex America Debuts High end Sample Management System During AACC 52129 3Understanding Managed Markets 3A Effective Market Research Structures 26 Activities to Maximize Payer Access 26 Insights 13093 1Understanding Managed Markets 3A Effective Market Research Structures 26 Activities to Maximize Payer Access 26 Insights 13093 2Internet May Be Newest Venue for Teen Tobacco Exposure 52122 1Internet May Be Newest Venue for Teen Tobacco Exposure 52122 2Internet May Be Newest Venue for Teen Tobacco Exposure 52122 3
...Presbycusis, or age-related hearing loss, accounts...ome people lose their hearing as they get older bu... answer may be in a study released online in the j...is available online at http://hmg.oxfordjournals....r and largest genome-wide association study for ag...
...g widespread consumption advisories and uncertaint...at. Now researchers at North Carolina State Univer...sts and regulators around the country predict whic...levels a breakthrough that should help officials ...visories for specific water bodies and fish specie...
...oration of Stanford University,s Woods Institute f... World Wildlife Fundhas been awarded a two-year, $... Foundation to develop a software program for mapp...by temperate marine ecosystems. , Called Marine I...and Tradeoffs), the proposed software will give po...
Other Biology News:House Ear Institute, TGen and Belgian researchers identify gene in age-related hearing loss 2New model predicts hot spots for mercury in fish 2Natural Capital Project to develop conservation software 2
(Date:11/6/2009)... , QUINCY, Mass., Nov. 6 Myri..., biotech developer and manufacturer of renewable...s preferred technology provider Uhde GmbH, one of ...ly "Uhde"), announced an alliance for the engineer...nt,s biobased Succinic Acid plants based on renewa...
(Date:11/6/2009)... , SAN MATEO, Calif., Nov. 6 /PRNewswire-Firs..., Completed transfer of Qutenza(TM) E.U. Market... Made significant progress in commercial readiness...P Sales; Senior Director, Marketing; and Director,...win to board as director and Audit Committee chair...
(Date:11/6/2009)... , CALGARY, Nov. 6 /PRNewswire-FirstCall/ - O...colytics" or the "Company") today announced update...LYSIN(R) in patients with sarcomas metastatic to t...l Connective Tissue Oncology Society Meeting held ... The poster presentation, entitled "A Phase II Stu...
(Date:11/6/2009)... , The agenda for Arrowhe... Conference, which is set to take place on Februar... At this three day conference we will highlight ke...st speakers to share their experiences. , ...6, 2009 -- The agenda for Arrowhead’s 2010 ...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3
... Mass., Oct. 8 Inverness Medical,Innovations (Ame... a Scheme,Implementation Agreement with Panbio Ltd...ecurities Exchange, under which it is proposed tha...in Panbio for AUD 0.65 cash,per share. The propose...,Panbio at approximately AUD 41 million, or approx...
... HEIGHTS, N.J., Oct. 8 Clinsys Clinical,Research,... organization,today announced the relocation of it...y,s significant growth and plans for future expans...ter, New Jersey. "Our new headquarters, combined ..., North Carolina and Dusseldorf, Germany, offers m...
...October 8 Innovation in the pharma industry is,no... once small molecule,research provided the mainsta...making their presence felt. While the range of gen...s are providing the current focus for novel,discov...cules; the rules,for their development are differe...
Other Biology Technology:Inverness Medical Innovations Agrees to Acquire Panbio Ltd. 2Clinsys Clinical Research, Inc. Announces Relocation of Corporate Headquarters 2Updated Drug Development Scrip Report Responds to the Pharma Industry's Major Changes 2
...2000 instrument can be used as a fully functional,...ger Software provides the means to record and tabu...hese data can then be copied and pasted into comme...Excel or Lotus 123, or into a curve-fitting progra...
Corning Cryo Box, 81 Position, 4-5 ml, Non-Sterile from Sigma-Aldrich
...oarray Kit (V2), 2 x 11K will enable researchers t...housands of yeast genes and identify gene activity...array contains sequences representing probes repre...Saccharomyces cerevisiae, sourced from the Sacchar...
...e offers an intuitive, easy-to-use operating envir...data handling, and integration with regulatory com...ude data acquisition, re-analysis, custom reports,...k environments. LCMSsolutions assistant bar provid...
Biology Products: